Some studies have shown that specific anti-VEGF treatments inhibit neovascularization and significantly suppress tumor growth in HB, with surviving vascular systems showing dilation and increased vascular smooth muscle; anti-VEGF drugs could be promising therapeutic alternatives for children with HB (McCrudden et al., 2003). Here, VEGFA is linked to hemoglobin measurement.